Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Dermatologic 1CNS 1

Conditions

Neuroblastoma 44Ganglioneuroblastoma 5Medulloblastoma 4Glioblastoma 4Brain Neoplasms 4Gliosarcoma 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Rhabdoid Tumor 2Recurrence 2Pinealoma 2Oligodendroglioma 2Pyloric Stenosis, Hypertrophic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Neoplasm, Residual 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Radiotherapy 6Psychiatric Rehabilitation 6Filgrastim 6Methylprednisolone 5Melphalan 5Flow Cytometry 5Cyclophosphamide 5Therapeutics 4sargramostim 3Topotecan 3Thiotepa 3Polymerase Chain Reaction 3Early Intervention, Educational 3Dexamethasone 3Caspofungin 3Carboplatin 3Calcium Dobesilate 3Busulfan 3Antilymphocyte Serum 3liposomal amphotericin B 2Vorinostat 2Voriconazole 2Rituximab 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Itraconazole 2Immunologic Techniques 2Fentanyl 2Carmustine 2Aprepitant 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × Isotretinoin × CNS × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡